Thank you very much, Mr. Chair.
Welcome to our witnesses.
Ms. Norman, we just had a great panel, and we talked with representatives from the diabetes community, who talked about the pharmacare legislation. I want to pick up on a couple of things there. Obviously I'm not as steeped in the subject matter, so I hope you can help me understand a few things.
You referenced the Affordable Care Act in the U.S. as a positive example of coverage for contraceptives. Is that correct?